Post-Covid infection patients are likely to have lasting effects on brain function and have dementia. Now, US researchers have found an overlap between Covid-19 and brain changes that are common in Alzheimer's. It may help inform risk management and therapeutic strategies for coronavirus-associated cognitive impairment.
While some studies suggest that SARS-CoV-2 infects brain cells directly, others found no evidence of the virus in the brain.
To explore this further, they investigated potential associations between Covid-19 and neuroinflammation and brain microvascular injury, which are both hallmarks of Alzheimer's.
"We discovered that SARS-CoV-2 infection significantly altered Alzheimer's markers implicated in brain inflammation and that certain viral entry factors are highly expressed in cells in the blood-brain barrier," said lead author Feixiong Cheng, from Cleveland Clinic's Genomic Medicine Institute.
The findings are published in the journal Alzheimer's Research & Therapy.
The researchers also analyzed the genetic factors that enabled SARS-COV-2 to infect brain tissues and cells.
The researchers also found that individuals with the allele APOE E4/E4, the greatest genetic risk factor for Alzheimer's, had decreased expression of antiviral defense genes, which could make these patients more susceptible to Covid-19.
"Ultimately, we hope to have paved the way for research that leads to testable and measurable biomarkers that can identify patients at the highest risk for neurological complications with Covid-19," said Cheng.
(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT)
(At The Quint, we are answerable only to our audience. Play an active role in shaping our journalism by becoming a member. Because the truth is worth it.)